Article info
Original article
Chromogenic in situ hybridisation (CISH) is a powerful method to detect ALK-positive non-small cell lung carcinomas
- Correspondence to Dr Florian Wagner, Institut für Gewebediagnostik/MVZ, HELIOS Klinikum Emil von Behring, Walterhöferstrasse 11, 14165 Berlin, Germany; florian.wagner{at}helios-kliniken.de
Citation
Chromogenic in situ hybridisation (CISH) is a powerful method to detect ALK-positive non-small cell lung carcinomas
Publication history
- Received September 19, 2013
- Revised October 25, 2013
- Accepted October 27, 2013
- First published November 29, 2013.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions